Arch Therapeutics Inc (ARTH) Inventory Turnover Ratio, from third quarter 2024 to third quarter 2023, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Arch Therapeutics Inc   (ARTH)
 

Arch Therapeutics Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Arch Therapeutics Inc inventory turnover ratio, the Arch Therapeutics Inc 's ability to sell and replace its inventory in the third quarter 2024, sequentially increased to 0.07 in the third quarter 2024, a new company high. Average inventory processing period, for the Arch Therapeutics Inc in Jun 30 2024 quarter, has decreased to 5214 days, compare to 6083 days, in the Mar 31 2024 quarter.

Within Healthcare sector 411 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1472 in the second quarter 2024, to 1912.

ARTH Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Arch Therapeutics Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ARTH Inventory Turnover Ratio (Jun 30 2024)
III. Quarter		 (Mar 31 2024)
II. Quarter		 (Dec 31 2023)
I. Quarter		 (Sep 30 2023)
IV. Quarter		 (Jun 30 2023)
III. Quarter
Y / Y Inventory Growth -4.53 % -5.19 % -5.37 % -3.56 % -3.17 %
Y / Y Cost of Sales Growth 13.76 % 15.16 % 33.86 % 18231.5 % 8.1 %
Inventory Turnover Ratio (TTM) 0.07 0.06 0.06 0.06 0.04
ARTH's Total Ranking # 1912 # 1472 # 1012 # 1627 # 1510
Average inventory processing period 5454 5679 5950 6493 9309
Seq. Inventory Growth -0.7 % -0.47 % -2.1 % -1.33 % -1.39 %
Seq. Cost of Sales Growth -2.21 % -8.69 % 1.4 % 25.65 % -1.01 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 177
Healthcare Sector # 412
Overall Market # 1912

Inventory Turnover Ratio Statistics
High Average Low
0.07 0.04 0.01
(Jun 30 2024)   (Mar 31 2021)



ARTH Company Profile >> Back to ARTH Efficiency Comparisons >> Compare ARTH Inventory Turnover Ratio to its Competitors

Financial Statements
Arch Therapeutics Inc 's Inventories $ 1 Millions Visit ARTH's Balance sheet
Arch Therapeutics Inc 's Cost of Revenues TTM $ 0 Millions Visit ARTH's Income Statement
What are ARTH's Sales? Visit ARTH's Sales by Segment

Other Inventory Turnover Ratios
Arch Therapeutics Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
ARTH's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for ARTH's Competitors
Inventory Turnover Ratio for ARTH's Suppliers
Inventory Turnover Ratio for ARTH's Customers

You may also want to know
ARTH's Sales Growth Rates ARTH's Pe Price to earnings ratio ARTH's Receivables Turnover Ratio ARTH's Stock Quote
ARTH's Net Income Growth Rates ARTH's Ps Price to Sales ratio ARTH's Sales per Employee ARTH's Asset Turnover Ratio
ARTH's Net Margin ARTH's Pb Price to Book ratio ARTH's Financial Strength Ratios ARTH's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2024, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2024 Inventories at quarter ending Jun 30 2024
Nexalin Technology Inc   0.17 $ 0.026  Millions$ 0  Millions
Agios Pharmaceuticals Inc   0.16 $ 3.341  Millions$ 21  Millions
Uniqure N v   0.12 $ 0.449  Millions$ 4  Millions
Ptc Therapeutics inc   0.12 $ 3.700  Millions$ 32  Millions
Arch Therapeutics Inc   0.07 $ 0.090  Millions$ 1  Millions
Apellis Pharmaceuticals Inc   0.06 $ 7.900  Millions$ 140  Millions
Guided Therapeutics Inc   0.03 $ 0.022  Millions$ 1  Millions
Vireo Growth Inc.  0.03 $ 0.521  Millions$ 19  Millions

Date modified: 2026-06-22T16:42:32+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.